Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene. (Q53350536)

13 May 2018

title

Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene. (English)

1 reference

13 May 2018

intraepithelial neoplasia

1 reference

1 reference

based on heuristic

inferred from title

prostatic intraepithelial neoplasia

1 reference

4

Argiris Efstratiadis

1 reference

13 May 2018

Zhe Li

1

1 reference

13 May 2018

Matthias Szabolcs

series ordinal

2

1 reference

13 May 2018

Joseph D Terwilliger

series ordinal

3

1 reference

13 May 2018

language of work or name

English

0 references

publication date

9 January 2006

1 reference

13 May 2018

published in

Carcinogenesis

1 reference

13 May 2018

volume

27

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

1054-1067

1 reference

13 May 2018

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Pathological and molecular aspects of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

High-grade prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Prostate cancer in a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Isolation and characterization of mouse probasin: An androgen-regulated protein specifically expressed in the differentiated prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Regulation of a bifunctional mRNA results in synthesis of secreted and nuclear probasin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

The neu oncogene encodes an epidermal growth factor receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

p63 regulates commitment to the prostate cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Co-Expression of ErbB-Family Members in Human Breast Cancer: Her-2/neu is the Preferred Dimerization Candidate in Nodal-positive Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Gene expression profiles of human breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Multiclass cancer diagnosis using tumor gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Gene expression analysis of prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

ErbB2 Activation of ESX gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Trefoil factor 3 is overexpressed in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Expression of androgen receptor and growth factors in premalignant lesions of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Her-2/neu oncogene amplification in clinically localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

ONCOMINE: a cancer microarray database and integrated data-mining platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/CARCIN/BGI324

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGI324

1 reference

13 May 2018

1 reference

13 May 2018